PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer

被引：2
|
作者：
Cercek, Andrea [1 ]
Lumish, Melissa [1 ]
Sinopoli, Jenna [1 ]
Weiss, Jill [1 ]
Shia, Jinru [1 ]
Stadler, Zsofia [1 ]
Yaeger, Rona [1 ]
Smith, J. Joshua [1 ]
Saltz, Leonard [1 ]
Widmar, Maria [1 ]
Crane, Christopher [1 ]
Romesser, Paul [1 ]
Pappou, Emmanouil P. [1 ]
Paty, Philip [1 ]
Garcia-Aguilar, Julio [1 ]
Gonen, Mithat [1 ]
Weiser, Martin [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-2
引用
收藏
页码：S1381 / S1381
页数：1
相关论文
共 50 条
  • [31] Immune Marker Spatial Distribution and Clinical Outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced Colorectal Carcinomas
    Saberzadeh-Ardestani, Bahar
    Graham, Rondell P.
    McMahon, Sara
    Ahanonu, Eze
    Shi, Qian
    Williams, Crystal
    Hubbard, Antony
    Zhang, Wenjun
    Muranyi, Andrea
    Yan, Dongyao
    Jin, Zhaohui
    Shanmugam, Kandavel
    Sinicrope, Frank A.
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4268 - 4277
  • [32] PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer
    Liu, Ding-Xin
    Li, Dan-Dan
    He, Wan
    Ke, Chuan-Feng
    Jiang, Wu
    Tang, Jing-Hua
    Kong, Ling-Heng
    Li, Yuan
    Sui, Qiao-Qi
    Xiao, Bin-Yi
    Li, Wei-Rong
    Hong, Zhi-Gang
    Xu, Rui-Hua
    Pan, Zhi-Zhong
    Zhang, Xiao-Shi
    Ding, Pei-Rong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Reply
    Diaz, Luis A., Jr.
    Le, Dung T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20): : 1979 - 1979
  • [34] Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
    Pei, Fengyun
    Wu, Jingjing
    Zhao, Yandong
    He, Wan
    Yao, Qijun
    Huang, Meijin
    Huang, Jun
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 85 - 91
  • [35] Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies
    Graham, Laura S.
    Montgomery, Bruce
    Cheng, Heather H.
    Yu, Evan Y.
    Nelson, Peter S.
    Pritchard, Colin
    Erickson, Stephanie
    Alva, Ajjai
    Schweizer, Michael T.
    PLOS ONE, 2020, 15 (05):
  • [36] PD-1 blockade in deficient mismatch repair mixed adenoneuroendocrine carcinoma of the stomach: new hope for an orphan disease
    Ricco, Beatrice
    Salati, Massimiliano
    Reggiani Bonetti, Luca
    Dominici, Massimo
    Luppi, Gabriele
    TUMORI JOURNAL, 2020, 106 (06): : NP57 - NP62
  • [37] Clinical and molecular features of responders to PD-1 blockade for patients with microsatellite instability high or mismatch repair deficient advanced gastrointestinal tumors.
    Chida, Keigo
    Kawazoe, Akihito
    Kawazu, Masahito
    Nakamura, Yoshiaki
    Suzuki, Toshihiro
    Kitano, Shigehisa
    Nakatsura, Tetsuya
    Kuwata, Takeshi
    Shitara, Kohei
    Ikeda, Masafumi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer
    Wang, Yan
    Zhao, Liwei
    Zhang, Zhen
    Liu, Peng
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [39] Detection of Mismatch Repair Protein Expression by Immunohistochemistry on Cytopathology Specimens: Implications for PD-1 Blockade Therapy
    Gomez, Adam J.
    Yang, Soo-Ryum
    Long, Steven
    Longacre, Teri
    Kong, Christina
    LABORATORY INVESTIGATION, 2017, 97 : 96A - 96A
  • [40] Detection of Mismatch Repair Protein Expression by Immunohistochemistry on Cytopathology Specimens: Implications for PD-1 Blockade Therapy
    Gomez, Adam J.
    Yang, Soo-Ryum
    Long, Steven
    Longacre, Teri
    Kong, Christina
    MODERN PATHOLOGY, 2017, 30 : 96A - 96A
12345